What Paratek Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Radie Robert S | Director | Sep 21 | Disposition to Issuer · D | −20,000 | — | — | 0 |
| Radie Robert S | Director | Sep 21 | Disposition to Issuer · D | −53,000 | — | — | 20,000 |
| Dietz Thomas John | Director | Sep 21 | Disposition to Issuer · D | −20,000 | — | — | 0 |
| Dietz Thomas John | Director | Sep 21 | Disposition to Issuer · D | −49,250 | — | — | 20,000 |
| Stein Jeffrey | Director | Sep 21 | Disposition to Issuer · D | −20,000 | — | — | 0 |
| Stein Jeffrey | Director | Sep 21 | Disposition to Issuer · D | −48,625 | — | — | 20,000 |
| Peterson Kristine | Director | Sep 21 | Disposition to Issuer · D | −20,000 | — | — | 0 |
| Peterson Kristine | Director | Sep 21 | Disposition to Issuer · D | −59,000 | — | — | 20,000 |
| Baylor-Henry Minnie | Director | Sep 21 | Disposition to Issuer · D | −26,400 | — | — | 0 |
| Baylor-Henry Minnie | Director | Sep 21 | Disposition to Issuer · D | −32,800 | — | — | 26,400 |
| Loh Evan | CEO | Sep 21 | Disposition to Issuer · D | −258,750 | — | — | 0 |
| Loh Evan | CEO | Sep 21 | Disposition to Issuer · D | −1,069,231 | — | — | 258,750 |
| Woodrow Adam | President & Chief Commercial | Sep 21 | Disposition to Issuer · D | −126,750 | — | — | 0 |
| Woodrow Adam | President & Chief Commercial | Sep 21 | Disposition to Issuer · D | −622,284 | — | — | 126,750 |
| Franson Timothy R | Director | Sep 21 | Disposition to Issuer · D | −20,000 | — | — | 0 |
| Franson Timothy R | Director | Sep 21 | Disposition to Issuer · D | −52,000 | — | — | 20,000 |
| Bigham Michael | Exec. Chairman of the Board | Sep 21 | Disposition to Issuer · D | −228,750 | — | — | 0 |
| Bigham Michael | Exec. Chairman of the Board | Sep 21 | Disposition to Issuer · D | −1,129,282 | — | — | 228,750 |
| Haskel William M. | CLO, General Counsel & Sec. | Sep 21 | Disposition to Issuer · D | −89,250 | — | — | 0 |
| Haskel William M. | CLO, General Counsel & Sec. | Sep 21 | Disposition to Issuer · D | −357,774 | — | — | 89,250 |
Loading...
